<DOC>
	<DOCNO>NCT01437111</DOCNO>
	<brief_summary>This study assess effect 26 week once-weekly treatment MK-217A/Alendronate Sodium 70-mg/Vitamin D3 5600 IU Combination Tablet ( Fosamax Plus 70/5600 ) serum level 25-hydroxyvitamin D [ 25 ( OH ) D ] .</brief_summary>
	<brief_title>Study MK-217A/Alendronate Sodium 70-mg/Vitamin D3 5600 IU Combination Tablet ( MK-0217A-329 )</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Alendronate</mesh_term>
	<criteria>Man age 50 old , woman postmenopausal day sign informed consent menopausal least one year Meets bone mineral density ( BMD ) criterion Agree discontinue osteoporosis drug treatment duration study Any contraindication alendronate vitamin D Not ambulatory Has receive treatment anabolic steroid agent within past 12 month , systemic glucocorticoid , 2 week past 6 month , current use immunosuppressant , fluoride treatment dose great 1 mg/day 2 week within past 3 month , treat parathyroid hormone ( PTH ) 2 week within past 3 month , current use chemotherapy heparin , use growth hormone 2 week within past 6 month , use active hormonal vitamin D analogs past 2 month , current use vitamin A &gt; 10,000 IU daily , current use , lithium , anticonvulsant include barbiturate , hydantoin , carbamazepine , current use calcium supplement amount excess 1500 mg daily , and/or current use Vitamin D supplement History malignancy &lt; 5 year , except adequately treat basal cell squamous cell skin cancer situ cervical cancer One follow concomitant condition : Upper gastrointestinal ( GI ) disorder adequately control ; myocardial infarction , unstable angina , stroke revascularization condition within 3 month ; malabsorption syndrome ; primary secondary hyperparathyroidism adequately treat ; thyroid disease adequately control ; severe renal insufficiency ; uncontrolled genitourinary , cardiovascular , hepatic , renal , endocrine , hematologic , neurological , psychiatric , pulmonary disease ; uncontrolled hypertension ; new onset diabetes ( within 3 month ) , poorly control hyperglycemia , hypoglycemia cause ; evidence metabolic bone disease osteoporosis ; abnormal index calcium metabolism ; and/or active renal stone disease User illicit recreational drug recent history ( within last year ) drug alcohol abuse dependence Heavy consumer alcohol alcohol containing product .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Osteoporosis</keyword>
	<keyword>Postmenopausal</keyword>
</DOC>